Core Insights - Kuehn Law is investigating potential breaches of fiduciary duties by officers and directors of iRhythm Technologies, Inc. [1] - A federal securities lawsuit alleges that insiders at iRhythm misrepresented the Zio AT monitor's intended use and market potential, leading to artificially inflated stock prices [2] Company Overview - iRhythm Technologies, Inc. is facing scrutiny regarding its Zio AT monitor, which was marketed as an innovative product for high-risk patients [2] - The company’s stock was reportedly traded at inflated prices due to misleading information provided by insiders [2] Legal Context - Shareholders who purchased iRhythm stock prior to November 11, 2022, are encouraged to contact Kuehn Law for potential legal action [3] - Kuehn Law offers to cover all case costs for investors, emphasizing the importance of shareholder participation in maintaining market integrity [4]

Core Insights - ADIA Nutrition, Inc. has filed a provisional patent application for a novel medical protocol aimed at enhancing regenerative outcomes, marking a significant advancement in the field of regenerative medicine [1][2]. Company Overview - ADIA Nutrition, Inc. is based in Winter Park, Florida, and is publicly traded, focusing on advanced healthcare solutions, particularly in stem cell and regenerative products [5]. - The company operates through its lab division, AdiaLabs LLC, and is expanding its offerings to include insurance-billable wound care products [5][6]. Innovation and Intellectual Property - The newly filed provisional patent represents a proprietary protocol that utilizes unique procedural and biological mechanisms not previously explored in clinical practice, positioning the company as a leader in regenerative medicine [2][3]. - Securing this patent is a crucial step for the company to protect its intellectual property and accelerate the development of next-generation health solutions [3]. Strategic Development - The patent pending status allows ADIA to pursue research, partnerships, and commercialization opportunities over the next 12 months while maintaining confidentiality [3]. - The company is actively seeking strategic partnerships and encouraging clinic owners and healthcare practitioners to integrate its regenerative therapies into their practices [4]. Revenue Generation - ADIA generates revenue through service fees, product sales, equity stakes, and billing insurance for healthcare treatments [6]. - The company is also investing in aligned businesses, such as Cement Factory LLC, which focuses on health and wellness [6].

Core Viewpoint - Gorilla Technology Group Inc. will hold a conference call on November 18, 2025, to discuss its Q3 2025 financial results, which will be released prior to the call [1]. Group 1: Conference Call Details - The conference call is scheduled for November 18, 2025, at 8:30 a.m. Eastern time (5:30 a.m. Pacific time) [2]. - Participants can join the call using a toll-free number or an international line, with a conference ID provided for registration [2]. Group 2: Company Overview - Gorilla Technology Group Inc. is headquartered in London, U.K., and operates as a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, and IoT technology [3]. - The company offers a variety of solutions across sectors such as Government & Public Services, Manufacturing, Telecom, Retail, Transportation & Logistics, Healthcare, and Education, utilizing AI and Deep Learning Technologies [3]. Group 3: Technological Expertise - The company specializes in enhancing urban operations, security, and resilience through AI-driven products, including intelligent video surveillance, facial recognition, and advanced cybersecurity technologies [4]. - By integrating these technologies, Gorilla aims to empower Smart Cities, improving efficiency, safety, and overall quality of life for residents [4].

Group 1 - A class action securities lawsuit has been filed against Avantor, Inc. to recover losses for shareholders affected by alleged securities fraud between March 5, 2024, and October 28, 2025 [2][3] - The complaint alleges that Avantor's competitive positioning was misrepresented, indicating it was weaker than publicly stated, and that the company faced negative impacts from increased competition [3] - Defendants are accused of making materially false and misleading statements regarding the company's business operations and future prospects [3] Group 2 - Shareholders who suffered losses during the specified timeframe are encouraged to learn about their rights to seek recovery, with no cost or obligation to participate [4] - Levi & Korsinsky LLP is highlighted as a nationally-recognized securities litigation firm with a strong track record in securing recoveries for shareholders [5]

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for alleged securities fraud affecting shareholders between August 6, 2024, and August 4, 2025 [2]. Group 1: Lawsuit Details - The lawsuit claims that the company made false statements and concealed critical issues regarding the launch of its new product, Inspire V, which reportedly faced poor demand due to providers having excess inventory and reluctance to adopt the new treatment [3]. - It is alleged that Inspire Medical Systems failed to complete essential tasks for a successful product launch, including training and onboarding for treatment center customers, setting up IT systems, updating insurer claims software, and ensuring Medicare reimbursement was in place [3]. Group 2: Next Steps for Affected Shareholders - Shareholders who suffered losses during the specified timeframe are encouraged to seek information about their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a strong track record in securing recoveries for shareholders and has been ranked among the top securities litigation firms in the United States for seven consecutive years [5].

Core Viewpoint - Baytex Energy Corp. has announced the sale of its U.S. Eagle Ford assets for US$2.305 billion to focus on its higher-return Canadian operations, enhancing its financial position and shareholder returns [1][2][5]. Transaction Details - The transaction is valued at approximately $3.25 billion in cash and is expected to close in late 2025 or early 2026, pending regulatory approvals [1][5]. - A US$200 million deposit will be made by the buyer, which may be forfeited under certain conditions [5]. Strategic Focus - The divestiture allows Baytex to concentrate on its Canadian assets, particularly in heavy oil development and the Pembina Duvernay, which are expected to drive long-term value creation [6][8]. - The company aims to maintain a disciplined growth strategy with an annual production growth target of 3-5% at WTI prices of US$60-65 per barrel [11]. Financial Position - Post-transaction, Baytex will have a net cash position and plans to repay outstanding credit facilities and senior notes, resulting in an industry-leading financial position [6][8]. - The company intends to return a significant portion of the proceeds to shareholders, potentially through share buybacks and maintaining its current dividend of $0.09 per share [6][8]. Production and Reserves - The Canadian portfolio produced 65,000 boe/d in the first nine months of 2025, reflecting a 5% growth compared to 2024 [9]. - The Eagle Ford assets being sold had proved plus probable reserves of 401 million boe as of December 31, 2024, with Q3 2025 production averaging 82,765 boe/d [13]. Future Outlook - Baytex plans to provide detailed guidance for 2026 and a three-year outlook following the transaction's completion, highlighting its streamlined Canadian asset base [12]. - The company has identified approximately 212 drilling locations in the Pembina Duvernay and expects to transition to a one-rig drilling program targeting production of 20,000-25,000 boe/d by 2029-2030 [10].

Core Insights - BioHarvest Sciences Inc. will attend the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025, in New York, NY [2] - CEO Ilan Sobel will conduct one-on-one meetings with institutional investors during the event [3] - The company is experiencing strong momentum in both its consumer and CDMO divisions, with robust performance in its core VINIA® capsule business and new product lines [4] Company Performance - BioHarvest's VINIA® Daily Chews 2X Formula and VINIA® Blood Flow Hydration Solution are expanding the company's market reach [4] - The CDMO platform has achieved significant milestones, including advancements in plant-based exosome production and a new contract for developing a saffron compound [4] - The company successfully closed a $19.9 million equity offering, which is expected to support its goal of achieving adjusted EBITDA breakeven in the near term [4] Company Overview - BioHarvest is a leader in Botanical Synthesis, utilizing its patented technology to grow plant-based compounds without the need for the actual plants [5] - The company operates in two main business verticals: as a contract development and production organization (CDMO) and as a creator of proprietary nutraceutical health and wellness products [5]

Core Insights - The company has entered a three-year agreement with a U.S.-based Remote Video Monitoring (RVM) company, with a total contract value of $2.5 million, to deploy its SARA™ AI platform across the RVM's monitored accounts [1][3][4] Agreement Details - The initial annual value of the deployment is approximately $855,000, with full implementation expected within six months [3] - Once fully implemented, the annual recurring revenue is projected to approach $1 million as the RVM expands its customer base [3] Technology and Market Position - SARA is designed to autonomously monitor live video streams, identify relevant events, and respond in real time, providing a scalable alternative to traditional monitoring methods [4] - The project aims to replace three legacy system providers and transition over 1,000 video monitoring accounts currently managed overseas [3][4] Company Background - AITX, through its subsidiary RAD-I, is positioned to redefine the $50 billion U.S. security and guarding services industry with its AI-driven Solutions-as-a-Service model [6] - RAD-I solutions can provide cost savings of 35%-80% compared to traditional manned security services [6] Leadership and Expertise - The company is led by Steve Reinharz, who has extensive experience in the security services industry and is involved in various industry associations [9] - The leadership team includes professionals with backgrounds in law enforcement and robotics innovation, enhancing the company's capability to deliver effective solutions [9] Sales Pipeline - RAD-I has a prospective sales pipeline that includes over 35 Fortune 500 companies, indicating strong potential for future business growth [10]

Core Viewpoint - Tartisan Nickel Corp. is set to initiate a Phase 1 diamond drill program at its Kenbridge Nickel-Copper-Cobalt Project, aiming to enhance and upgrade existing resources and explore high-grade mineralization extensions [1][2][4]. Group 1: Drill Program Details - The Phase 1 drill program will encompass approximately 3600 meters of NQ diamond drilling [1][7]. - The program's focus includes converting inferred resources into Measured and Indicated categories and testing extensions of high-grade nickel-copper mineralization below the existing 623-meter shaft [2][7]. - Drill targets have been prioritized based on previous exploration results and downhole geophysical modeling [3]. Group 2: Project Objectives and Infrastructure - Key objectives of the Phase 1 program include improving geological and metallurgical understanding to support a potential Pre-Feasibility Study (PFS) and collecting new data for future mine design and resource conversion [7]. - The Kenbridge Nickel Project area covers approximately 4,273 hectares of patented and staked claims, with excellent infrastructure access via road from Sioux Narrows and Kenora, Ontario [3]. Group 3: Company Overview - Tartisan Nickel Corp. is a Canadian mineral exploration and development company that owns the Kenbridge Nickel Project, along with other projects in Ontario [4]. - The company currently has 130,995,782 shares outstanding, with a fully diluted total of 137,784,671 shares [4].

Core Insights - Eco Wave Power has made significant advancements in Q3 2025, including the launch of its first U.S. project and recognition by TIME as one of the Best Inventions of 2025, supporting its global growth in wave energy technology [1][8][24]. Financial Overview - For the nine months ended September 30, 2025, operating expenses increased to $2.48 million from $1.97 million in the same period of 2024, primarily due to investments in U.S., Portugal, and Asia projects [32]. - Operating expenses for Q3 2025 were $888 thousand, reflecting an 8% increase quarter-over-quarter, driven by higher Sales & Marketing costs to support the U.S. project launch [21][30]. - The net loss for Q3 2025 was $996 thousand, a 28% reduction from the previous quarter, indicating improved operational efficiency [22][30]. Project Developments - The U.S. pilot project at the Port of Los Angeles was launched in September 2025, marking the first onshore wave energy installation in the U.S. [4][5]. - In Taiwan, Eco Wave Power has entered an agreement for local manufacturing and installation of a wave energy pilot station, marking a significant step in the country's renewable energy sector [9][10]. - The company is advancing preparations for Portugal's first megawatt-scale wave energy power plant, with plans for grid connection in 2026 [14][15]. International Recognition - The U.S. pilot project was featured on Good Morning America, providing unprecedented visibility for wave energy technology [3][24]. - Eco Wave Power's pilot project was named one of TIME's Best Inventions of 2025, highlighting its impact on climate change and sustainability [8][24]. Strategic Partnerships - Collaborations with local partners in the U.S., including AltaSea and Shell Marine Renewable Energy, emphasize the company's commitment to innovation and community engagement [25]. - In India, a Memorandum of Understanding with Bharat Petroleum Corporation Limited aims to explore wave energy deployment at the Mumbai Oil Terminal, tapping into a significant ocean energy market [12][13]. Research and Development - The EWP-EDF One project in Israel is focused on optimizing system performance through advanced testing and calibration, reinforcing Eco Wave Power's position as a global R&D hub for wave energy [16][18]. - The company is investing in R&D to lower equipment costs and enhance the scalability of its wave energy solutions [19][31].